Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
US7829529B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2008 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Jan 4, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to cell migration or treated by specific regulation of cell migration or chemotaxis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.